These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 22234056

  • 21. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
    Lee KW, Park JW, Joh JW, Kim SJ, Choi SH, Heo JS, Lee HH, Lee DS, Park JH, Yoo BC, Paik SW, Koh KC, Lee JH, Choi MS, Lee SK.
    Transplant Proc; 2004 Oct; 36(8):2289-90. PubMed ID: 15561222
    [Abstract] [Full Text] [Related]

  • 22. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
    Oya H, Sato Y, Yamamoto S, Nakatsuka H, Kobayashi T, Hara Y, Waguri N, Suda T, Aoyagi Y, Hatakeyama K.
    Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
    [Abstract] [Full Text] [Related]

  • 23. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA.
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [Abstract] [Full Text] [Related]

  • 24. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

  • 25. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 26. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 27; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 27. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
    Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L.
    Hepatogastroenterology; 2012 Jan 27; 59(114):505-10. PubMed ID: 22353516
    [Abstract] [Full Text] [Related]

  • 28. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.
    Fan ST, Poon RT, Yeung C, Lam CM, Lo CM, Yuen WK, Ng KK, Liu CL, Chan SC.
    Br J Surg; 2011 Sep 27; 98(9):1292-300. PubMed ID: 21656513
    [Abstract] [Full Text] [Related]

  • 29. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.
    Liver Transpl; 2004 Nov 27; 10(11):1343-54. PubMed ID: 15497158
    [Abstract] [Full Text] [Related]

  • 30. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
    Fan J, Zhou J, Xu Y, Qiu SJ, Wu ZQ, Yu Y, Huang XW, Tang ZY, Wang YQ.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1227-31. PubMed ID: 16796876
    [Abstract] [Full Text] [Related]

  • 31. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y.
    J Am Coll Surg; 2015 Mar 16; 220(3):297-304.e3. PubMed ID: 25617912
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation for hepatocellular carcinoma: defining the impact of using extended criteria liver allografts.
    Facciuto ME, Singh MK, Katta U, Samaniego S, Sharma J, Rodriguez-Davalos M, Sheiner P, Kim-Schluger L, Wolf DC.
    Transplantation; 2011 Aug 27; 92(4):446-52. PubMed ID: 21694662
    [Abstract] [Full Text] [Related]

  • 33. Liver transplantation for hepatocellular carcinoma: Korean experience.
    Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, Chung D, Park G, Yu Y, Choi N, Kim K, Kim K, Hwang S.
    J Hepatobiliary Pancreat Sci; 2010 Sep 27; 17(5):539-47. PubMed ID: 19727542
    [Abstract] [Full Text] [Related]

  • 34. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J.
    Liver Transpl; 2008 Mar 27; 14(3):272-8. PubMed ID: 18306328
    [Abstract] [Full Text] [Related]

  • 35. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Wong J.
    Liver Transpl; 2004 Mar 27; 10(3):440-7. PubMed ID: 15004774
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
    Malagó M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Radtke A, Saner F, Molmenti E, Beckebaum S, Gerken G, Frilling A, Broelsch CE.
    Liver Transpl; 2006 Jun 27; 12(6):934-40. PubMed ID: 16528715
    [Abstract] [Full Text] [Related]

  • 38. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N.
    Liver Transpl; 2011 Oct 27; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [Abstract] [Full Text] [Related]

  • 39. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG.
    Hepatobiliary Pancreat Dis Int; 2010 Aug 27; 9(4):366-9. PubMed ID: 20688599
    [Abstract] [Full Text] [Related]

  • 40. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
    Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, Ogawa K, Sakamoto S, Ogura Y, Egawa H, Tanaka K, Uemoto S.
    Liver Transpl; 2007 Dec 27; 13(12):1637-44. PubMed ID: 18044766
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.